Fentanyl Injection Bags Recalled Due to Incorrect Barcode Labels
Hikma Injectables USA Inc. has recalled 1,895 bags of Fentanyl 1000mcg/100mL injection (lot CH0324001) due to incorrect barcodes on the product labeling.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III recall with a labeling error and no reported illnesses, injuries, or product defects. Minor labeling errors are classified as Moderate severity per the FDA rubric.
Plain-English summary
Hikma Injectables USA Inc. is recalling 1,895 bags of Fentanyl 1000mcg/100mL (10mcg/mL) in 0.9% Sodium Chloride Injection that were distributed nationwide. The recalled product has lot number CH0324001 with an expiration date of March 4, 2025. The recall has been initiated due to incorrect barcode labels on the product.
The incorrect barcode may affect proper product identification and inventory tracking in healthcare settings. Healthcare providers and facilities that received this lot should verify they have the affected product and implement appropriate measures to ensure correct product identification.
If you have the recalled product with lot number CH0324001, contact Hikma Injectables USA Inc. Do not use the product until the barcode has been verified or the product has been replaced with a correctly labeled version.
The recalled product
- Product
- Fentanyl 1000mcg/100mL (10mcg/mL) in 0.9% Sodium Chloride Injection, packaged in 100mL bags, Rx only, Compounded by: Hikma Injectables USA Inc. 2 Esterbrook Lane, Cherry Hill, NJ 08003, Distributed by: Hikma Injectables USA Inc. 36 Stults Road, Dayton, NJ 08810, NDC 63037-100-05
- Manufacturer
- Hikma Injectables USA Inc
- Category
- Drug — Injectable / Fentanyl
- Hazard
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: CH0324001
- Exp. Date 3/4/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27